Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide due to high recurrence rates after curative treatment and being frequently diagnosed at an advanced stage. Immune-checkpoint inhibition (ICPI) has yielded impressive clinical successes in a variety of solid...

Descripción completa

Detalles Bibliográficos
Autores principales: Noordam, Lisanne, de Beijer, Monique T.A., Mancham, Shanta, Vogler, Isabel, Boor, Patrick P.C., de Ruiter, Valeska, Luijten, Robbie, IJzermans, Jan N.M., Sahin, Ugur, Bruno, Marco J., Sprengers, Dave, Buschow, Sonja I., Kwekkeboom, Jaap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542711/
https://www.ncbi.nlm.nih.gov/pubmed/36211805
http://dx.doi.org/10.1080/2162402X.2022.2131096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542711/
https://www.ncbi.nlm.nih.gov/pubmed/36211805
http://dx.doi.org/10.1080/2162402X.2022.2131096

Ejemplares similares